Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 452-810-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004-01-06 to 2004-03-11
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Commission Directive 2000/32/EC, Annex 4C (dated 2000-05-19)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ICH-Harmonised Tripartite Guideline S2A and S2B (CPMP/ICH/141/95; CPMP/ICH/174/95)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material (as cited in study report): T002251
- Physical state: Solid
- Appearance: Brown powder
Constituent 1
- Specific details on test material used for the study:
- Batch No.: 00410155
Aggregate State at Room Temperature: Solid
Colour: Brown
Purity: 96%
Stability in Solvent: Not indicated by the Sponsor
Storage: At room temperature
Expiration Date: May 05, 2004
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd., Biotechnology and Animal Breeding Division; CH-4414 Füllinsdorf
- Age at study initiation: 5-7 weeks (males); 7-9 weeks (females)
- Weight at study initiation: males mean value 29.7g (SD +/- 2.2g); females mean value 25.0g (SD +/- 1.7g)
- Assigned to test groups randomly: yes, and identified by cage number
- Fasting period before study: the animals were starved over night but received water ad libitum
- Housing: single, Makrolon Type I, with wire mesh top
- Diet (e.g. ad libitum): pelleted standard diet, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: minimum 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 °C
- Humidity (%): 25 - 72%
- Photoperiod (hrs dark / hrs light): 12h light (artificial) / 12h dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: polyethylene glycol 400 (PEG 400)
- Justification for choice of solvent/vehicle: The vehicle was chosen to its relative non-toxicity for the animals
- Concentration of test material in vehicle: adequate spaced dose levels
- Amount of vehicle (if gavage or dermal): All animals received a single standard volume of 20 ml/kg body weight orally. - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: On the day of the experiment, the test item was formulated in PEG 400.
- Duration of treatment / exposure:
- 24h and 48h (only highest dose level)
- Frequency of treatment:
- The animals received the test item, the vehicle or the positive control substance once.
- Post exposure period:
- Examination of animals of all dose groups for acute toxic symptoms at intervals of around 1h, 2-4h, 6h and 24h after administration of the test item.
Sampling of the bone marrow was done 24 and 48 hours after treatment.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day
- Remarks:
- Negative control
24h sampling time
- Dose / conc.:
- 150 mg/kg bw/day (nominal)
- Remarks:
- Test group
24h sampling time
- Dose / conc.:
- 300 mg/kg bw/day (nominal)
- Remarks:
- Test group
24h sampling time
- Dose / conc.:
- 600 mg/kg bw/day (nominal)
- Remarks:
- Test group
24h and 48h sampling time
- Dose / conc.:
- 40 mg/kg bw/day (actual dose received)
- Remarks:
- Positive control
24h sampling time
- No. of animals per sex per dose:
- Six males and six females were assigned to eaeh test group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): no data
- Route of administration: single oral administration
- Doses / concentrations: 40 mg/kg b.w. (volume administered 10 ml/kg b.w.)
- Other: dissolved in deionised water; solution prepared on day of administration
Examinations
- Tissues and cell types examined:
- bone marrow tissue - at least 2000 polychromatic erythrocytes were analysed per animal for micronuclei
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: It is generally recommended to use the maximum tolerated dose or the highest dose that can be formulated and administered reproducibly or 2000 mg/kg as the upper limit for non-toxic test items. The maximum tolerated dose level is determined to be the dose that causes toxic reactions without having major effects on survival within 48 hours. The volume to be administered should be compatible with physiological space available.
Three adequate spaced dose levels spaced by a factor of 2 were applied at the central sampling interval 24h after treatment. For the highest dose level an additional sample was taken at 48h after treatment.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): The animals were starved over night but received water ad libitum. At the beginning of the treatment the animals (including the controls) were weighed and the individual volume to be administered was adjusted to the animals body weight. The animals received the test item, the vehicle or the positive control substance once. Twelve animals, six males and six females, were treated per dose group and sampling time. The animals of all dose groups were examined for acute toxic symptoms at intervals of around 1h, 2-4h, 6h and 24h after administration of the test item.
Sampling of the bone marrow was done 24h and 48h after treatment, respectively.
DETAILS OF SLIDE PREPARATION: The animals were sacrificed with CO2 and cervical dislocation. The femora were removed, the epiphyses were cut off and the marrow was flushed out with fetal calf serum, using a syringe. The cell suspension was centrifuged at 1500 rpm (390 x g) for 10 minutes and the supernatant was discarded. A small drop of the resispended cell pellet was spread on a slide. The smear was air-dried and then stained with May-Grünwald / Giemsa. Cover slips were mounted with EUKITT. At least one slide ws made from each bone marrow sample.
METHOD OF ANALYSIS: Evaluation of the slides was performed using NIKON microscopes with 100x oil immersion objectives. At least 2000 polychromatic erythrocytes (PCE) were analysed per animal for micronuclei. To describe a cytotoxic effect the ratio between polychromatic and total erythrocytes was determined in the same sample and expressed in polychromatic erythrocytes per 2000 erythrocytes. The analysis was performed with coded slides.
Ten animals (5 males / 5 females) per test group were evaluated as described. The remaining 6th animal of each group and sex is evaluated in case an animal of that group dies. - Evaluation criteria:
- A test item is classified as mutagenic if it induces either a dose-related increase or a clear increase in the number of micronucleated polychromatic erythrocytes in a single dose group. Statistical methods (nonparametric Mann-Whitney test) will be used as an aid in evaluating the results. However, the primary point of consideratrion is the biological relevance of the results.
A test item that fails to produce a biological relevant increase in the number of micronucleated polychromatic erythrocytes is considered non-mutagenic in this system. - Statistics:
- Statistical significance at the five per cent level (p < 0.05) was evaluated by means of the non-parametric Mann-Whitney test.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- 2 males and 1 female died after treatment with 600 mg/kg b.w. in main experiment (no deaths at 600 mg/kg b.w. in pre-experiment)
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 500, 600, 750 and 1000 mg/kg b.w.
- Solubility: soluble
- Clinical signs of toxicity in test animals: reduction of spontaneous activity, adbominal position, eyelid closure, ruffled fur, apathy, death
- Evidence of cytotoxicity in tissue analyzed: To describe a cytotoxic effect due to the treatment with the test item the ratio between polychromatic and total erythrocytes was determined in the same sampie and reported as the number of PCEs per 2000 erythrocytes.
- Harvest times: 24h and 48h (for highest dose level)
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): In comparison to the corresponding vehicle controls there was no statistically significant or biologically relevant enhancement in the frequency of the detected micronuclei at any preparation interval and dose level after administration of the test item. The mean values of micronuclei observed after treatment with T002251 were below or near to the value of the vehicle control group.
The following percentages of PCEs with micronuclei were calculated:
a) vehicle (24h): 0.055%
b) test item 150 mg/kg b.w. (24h): 0.075%
c) test item 300 mg/kg b.w. (24h): 0.070%
d) test item 600 mg/kg b.w. (24h): 0.060%
e) positive control 40 mg/kg b.w. (24h): 2.185%
f) test item 600 mg/kg b.w. (48h): 0.030%
- Ratio of PCE/NCE (for Micronucleus assay):
a) vehicle (24h): 1103/2000
b) test item 150 mg/kg b.w. (24h): 1042/2000
c) test item 300 mg/kg b.w. (24h): 1082/2000
d) test item 600 mg/kg b.w. (24h): 1088/2000
e) positive control 40 mg/kg b.w. (24h): 1123/2000
f) test item 600 mg/kg b.w. (48h): 863/2000
- Appropriateness of dose levels and route: determined via pre-experiment
- Statistical evaluation: no statistically significant or biologically relevant enhancement in the frequency of the detected micronuclei at any preparation interval and dose level
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
In conclusion, it can be stated that during the study described and under the experimental conditions reported, the test item did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the mouse.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Deși ECHA oferă o varietate bogată de materiale online în limba dumneavoastră, o parte din conţinutul acestei pagini este disponibil numai în limba engleză. Pentru mai multe informaţii referitoare la practica multilingvă a ECHA.
Bun venit pe site-ul ECHA. Acest site nu este deplin acceptat în Internet Explorer 7 (și versiuni anterioare). Vă rugăm să vă actualizați versiunea de Internet Explorer.
Acest site folosește module cookie pentru a garanta că aveți parte de cea mai bună experiență pe paginile noastre.
Aflați mai multe despre cum folosim modulele cookie.